查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球 CRISPR 與 Cas 基因市場
市場調查報告書
商品編碼
1380259

2023-2030 年全球 CRISPR 與 Cas 基因市場

Global CRISPR and Cas Genes Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

根據美國國立衛生研究院 (NIH) 的數據，2022 年 12 月，CRISPR/Cas9 是主要工具 (85%)，其次是 TALEN (3.0%)。水稻（13.0%）、番茄（7.0%）和小麥/大麥（3%）是研究最多的植物，而豬（7.0%）、雞（2.0%）和牛（2.0%）是主要動物物種被調查的。

細分市場前景

全球 CRISPR 和 Cas 基因市場按產品類型、服務類型和垂直行業細分。根據產品類型，市場分為基於載體的 Cas 和無 DNA Cas。根據服務類型，市場細分為細胞系工程、gRNA 設計、微生物基因編輯和 DNA 合成。根據應用，市場細分為基因組工程、疾病模型、功能基因體學等。此外，根據最終用戶，市場又細分為生物技術公司以及製藥、學術和政府研究機構以及 CRO。在這些服務類型中，由於可用於編輯微生物內基因的 CRISPR-Cas9 的開發不斷增加，微生物基因編輯細分市場預計將佔據相當大的市場佔有率。這種編輯過程具有廣泛的應用，包括基礎生物學研究、生物技術產品的開發和疾病的治療。 ICRISPR-Cas系統也被用於治療其他血液疾病，例如鐮狀細胞疾病（SCD）和B型血友病（HB）。它不僅限於治療遺傳性疾病，而且還被發現對治療轉移性癌症有效。

預計基因組工程細分市場將在全球 CRISPR 和 CAS 基因市場中佔據相當大的佔有率

其中，基因組工程細分領域預計將在全球CRISPR和Cas基因市場中佔據相當大的佔有率。分段成長歸因於CRISPR和Cas技術在糾正致病突變、尋找癌症免疫治療必需基因以及解決器官異種移植關鍵問題等領域的影響力日益增強。 CRISPR 和 Cas 基因產品的推出標誌著針對快速發展的基因組編輯和基因功能修改領域的專用解決方案。例如，2021 年 6 月，QIAGEN 推出了專用 CRISPR 產品，用於快速、簡化地分析基因編輯實驗。該公司推出了 QIAprep& CRISPR Kit 和 CRISPR Q-Primer Solutions，使研究人員能夠以無與倫比的速度和效率分析編輯後的遺傳物質，以確定他們的干涉措施如何改變了相關 DNA 序列的功能。

區域展望

全球 CRISPR 和 Cas 基因市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國） 、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，北美地區預計將在全球市場中佔據顯著佔有率，因為增強型單一產品的可用性，例如簡單的基因敲除、選擇性基因組切割、減少脫靶切割、基因組工程和更高的特異性。主要市場參與者包括Addgene Inc.、Danaher Corp.、GenScript Biotech、Takara Bio Inc.、賽默飛世爾科技公司等。

亞太地區全球 CRISPR 和 Cas 基因市場預計將以顯著的CAGR成長

在所有地區中，亞太地區預計在預測期內將以可觀的CAGR成長。區域成長歸因於政府增加研發投資以開發新療法，有助於市場擴張日本和中國預計將支持該地區的成長。例如，2021 年 3 月，日本生物技術公司 Setsuro Tech 從都柏林 ERS ​​Genomics 獲得了 CRISPR-Cas9 技術的專利。該公司正在利用這些先進技術創建動物和細胞模型。預計此類措施將增強該地區 CRISPR 技術的採用，進一步促進創造收入。

市場參與者展望

服務於 CRISPR 和 Cas Genes 市場的主要公司包括： Danaher Corp.、GenScript Biotech、Merck KGaA、Thermo Fisher Scientific, Inc.、Bio-Rad Laboratories, Inc.、GE Healthcare、Qiagen NV 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2020 年6 月，Regeneron Pharmaceuticals, Inc. 和Intellia Therapeutics, Inc. 合作，為Regeneron 提供開發其他基於CRISPR/Cas9 的體內治療靶點的產品的權利，並讓兩家公司共同開發用於治療的潛在產品血友病A和B。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球 CRISPR 和 Cas 基因市場的主要營運公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Danaher Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • GenScript Biotech
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Thermo Fisher Scientific, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Merck KGaA
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按產品類型分類的全球 CRISPR 和 Cas 基因市場
    • 基於向量的Cas
    • 無 DNA Cas
  • 按服務類型分類的全球 CRISPR 和 Cas 基因市場
    • 細胞系工程
    • gRNA設計
    • 微生物基因編輯
    • DNA合成
  • 全球 CRISPR 和 Cas 基因市場（按應用）
    • 基因組工程
    • 疾病模型
    • 功能基因體學
    • 其他（表觀遺傳學和生物醫學）
  • 最終用戶的全球 CRISPR 和 Cas 基因市場
    • 生技公司和製藥公司
    • 學術與政府研究所
    • 合約研究組織 (CRO)

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • ACROBiosystems, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Caribou Biosciences, Inc.
  • Cell Biolabs, Inc.
  • Cellecta, Inc.
  • Creative Biogene.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GE Healthcare
  • Horizon Discovery Group plc
  • Illumina, Inc.
  • Inscripta, Inc.
  • Integrated DNA Technologies, Inc.
  • Lonza Group AG
  • New England Biolabs
  • OriGene Technologies, Inc.
  • Qiagen NV
  • Synthego Corp.
  • Takara Bio Inc.
Product Code: OMR2027809

Title: Global CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product Type (Vector-based Cas and DNA-free Cas), by Service Type (Cell Line Engineering, gRNA design, Microbial Gene Editing and DNA Synthesis), by Application (Genome Engineering, Disease Models, Functional Genomics and Other) and by End Users (Biotechnology Companies & Pharmaceutical, Academic and Government Research Institute and CROs),Forecast Period (2023-2030).

Global CRISPR and Cas genes market is anticipated to grow at a CAGR of 13.5% during the Forecast Period (2023-2030). CRISPR-Cas systems are the most widely used genome editing technology in molecular biology laboratories around the globe. The growing adoption of CRISPR-based screens with the improving genomic target is the key factor supporting the growth of the market globally. According to the National Institute of Health (NIH), in April 2020, CRISPR-based screens demonstrated improved versatility, efficacy, and lower off-target effects compared with approaches such as RNAi. Genome-wide CRISPR screen has emerged as a powerful tool for performing large-scale loss-of-function screens, with low noise, high knockout efficiency, and minimal off-target effects. Hence, the market players are also focusing on introducing CRISPR genome-wide knockout library solutions that further bolster the market growth. For instance, in October 2023, Cellecta, Inc. launched genome-wide CRISPR Chicken and Pig Knockout Libraries. Cellecta, Inc. released new pooled, single-module, CRISPR genome-wide knockout libraries for chicken (Gallus gallus) and pig (Sus scrofa). The new libraries allow the study of gene disruptions in a single experiment to enable improved breeding and more.

According to the National Institute of Health (NIH), in December 2022, CRISPR/Cas9 was the predominant tool (85%), followed by TALEN (3.0%). Rice (13.0%), tomato (7.0%), and wheat/barley (3%) were the most studied plants, whereas pig (7.0%), chicken (2.0%), and cow (2.0%) were the main animal species that were investigated.

Segmental Outlook

The global CRISPR and Cas genes market is segmented on the product type, service type, and industry verticals. Based on the product type, the market is sub-segmented into vector-based Cas and DNA-free Cas. Based on the service type, the market is sub-segmented into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis. Based on the application, the market is sub-segmented into genome engineering, disease models, functional genomics, and others. Further, based on end users, the market is sub-segmented into biotechnology companies and pharmaceutical, academic, and government research institutes and CROs. Among the service types, the microbial gene editing sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of CRISPR-Cas9 which can be used to edit genes within microorganisms. This editing process has a wide variety of applications including basic biological research, development of biotechnological products, and treatment of diseases. ICRISPR-Cas systems have also been used for the treatment of other hematologic diseases, such as sickle cell disease (SCD) and hemophilia B (HB). It is not only limited to the treatment of genetic disorders but also it has been found effective for the treatment of metastatic cancer.

The Genome Engineering Sub-Segment is Anticipated to Hold a Considerable Share of the Global CRISPR and CAS genes Market

Among the applications, the genome engineering sub-segment is expected to hold a considerable share of the global CRISPR and Cas genes market. The segmental growth is attributed to the growing influence of CRISPR and Cas technology in the field of correcting pathogenic mutations, searching for essential genes for cancer immunotherapy, and solving key problems in organ xenotransplantation. CRISPR and Cas genes product launch marks dedicated solutions specific to the fast-growing field of editing genomes and modifying gene function. For instance, in June 2021, QIAGEN launched dedicated CRISPR Products for rapid and simplified analysis of gene-editing experiments. The company launched QIAprep& CRISPR Kit and CRISPR Q-Primer Solutions that allow researchers to analyze edited genetic material with unparalleled speed and efficiency to determine how their interventions have changed the function of the DNA sequence in question.

Regional Outlook

The global CRISPR and Cas genes market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the availability of enhanced individual products such as simple gene knockouts, selective genome cleavage, reduced off-target cutting, genome engineering, and higher specificity. The key market players include Addgene Inc., Danaher Corp., GenScript Biotech, Takara Bio Inc., Thermo Fisher Scientific, Inc., and others.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global CRISPR and Cas Genes Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to increasing government investment in R&D to develop novel treatments is aiding in market expansion Japan and China are anticipated to support the region's growth. For instance, in March 2021, Japanese biotech company Setsuro Tech received a patent for CRISPR-Cas9 technology from Dublin-based ERS Genomics. The company is creating animal and cell models using these advanced technologies. Such initiatives are predicted to enhance CRISPR technology adoption in the region, further contributing towards revenue generation.

Market Players Outlook

The major companies serving the CRISPR and Cas Genes market include: Danaher Corp., GenScript Biotech, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Qiagen NV, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2020, Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. collaborated to provide Regeneron with rights to develop products for additional in vivo CRISPR/Cas9-based therapeutic targets and for the companies to jointly develop potential products for the treatment of hemophilia A and B.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global CRISPR and Cas genes market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Danaher Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GenScript Biotech
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Merck KGaA
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global CRISPR and Cas Genes Market by Product Type
    • 4.1.1. Vector-based Cas
    • 4.1.2. DNA-free Cas
  • 4.2. Global CRISPR and Cas Genes Market by Service Type
    • 4.2.1. Cell Line Engineering
    • 4.2.2. gRNA Design
    • 4.2.3. Microbial Gene Editing
    • 4.2.4. DNA Synthesis
  • 4.3. Global CRISPR and Cas Genes Market by Application
    • 4.3.1. Genome Engineering
    • 4.3.2. Disease Models
    • 4.3.3. Functional Genomics
    • 4.3.4. Other (Epigenetics and Biomedical)
  • 4.4. Global CRISPR and Cas Genes Market by End Users
    • 4.4.1. Biotechnology Companies & Pharmaceutical
    • 4.4.2. Academic and Government Research Institute
    • 4.4.3. Contract Research Organizations (CROs)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. ACROBiosystems, Inc.
  • 6.2. Agilent Technologies, Inc.
  • 6.3. Bio-Rad Laboratories, Inc.
  • 6.4. Caribou Biosciences, Inc.
  • 6.5. Cell Biolabs, Inc.
  • 6.6. Cellecta, Inc.
  • 6.7. Creative Biogene.
  • 6.8. CRISPR Therapeutics AG
  • 6.9. Editas Medicine, Inc.
  • 6.10. GE Healthcare
  • 6.11. Horizon Discovery Group plc
  • 6.12. Illumina, Inc.
  • 6.13. Inscripta, Inc.
  • 6.14. Integrated DNA Technologies, Inc.
  • 6.15. Lonza Group AG
  • 6.16. New England Biolabs
  • 6.17. OriGene Technologies, Inc.
  • 6.18. Qiagen NV
  • 6.19. Synthego Corp.
  • 6.20. Takara Bio Inc.

LIST OF TABLES

  • 1. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL VECTOR-BASED CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL DNA-FREE CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 5. GLOBAL CRISPR AND CAS GENES FOR CELL LINE ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL CRISPR AND CAS GENES FOR GRNA DESIGN MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL CRISPR AND CAS GENES FOR MICROBIAL EDITING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL CRISPR AND CAS GENES FOR DNA SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL CRISPR AND CAS GENES FOR GENOME ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CRISPR AND CAS GENES FOR DISEASE MODELS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL CRISPR AND CAS GENES FOR FUNCTIONAL GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL CRISPR AND CAS GENES FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 15. GLOBAL CRISPR AND CAS GENES FOR BIOTECHNOLOGY COMPANIES & PHARMACEUTICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL CRISPR AND CAS GENES FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL CRISPR AND CAS GENES FOR CROS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 24. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 26. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 27. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 29. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 31. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL VECTOR-BASED CRISPR AND CAS GENES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL DNA-FREE CRISPR AND CAS GENES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY SERVICE TYPE, 2022 VS 2030 (%)
  • 5. GLOBAL CRISPR AND CAS GENES FOR CELL LINE ENGINEERING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 6. GLOBAL CRISPR AND CAS GENES FOR GRNA DESIGN MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL CRISPR AND CAS GENES FOR MICROBIAL EDITING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 8. GLOBAL CRISPR AND CAS GENES FOR DNA SYNTHESIS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 9. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 10. GLOBAL CRISPR AND CAS GENES FOR GENOME ENGINEERING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL CRISPR AND CAS GENES FOR DISEASE MODELS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL CRISPR AND CAS GENES FOR FUNCTIONAL GENOMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL CRISPR AND CAS GENES FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY END USERS, 2022 VS 2030 (%)
  • 15. GLOBAL CRISPR AND CAS GENES FOR BIOTECHNOLOGY COMPANIES & PHARMACEUTICAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL CRISPR AND CAS GENES FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL CRISPR AND CAS GENES FOR CROS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. US CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CANADA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. UK CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. FRANCE CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. GERMANY CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. ITALY CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SPAIN CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF EUROPE CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. INDIA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. CHINA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. JAPAN CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. SOUTH KOREA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. LATIN AMERICA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. MIDDLE EAST AND AFRICA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)